Neurostar

Risk score

57

Headquarters

Flag of United States of AmericaUnited States of America

We formulated NeuroStar as a non-invasive therapeutic option for managing individuals with major depressive disorder and targeting numerous of the main constraints of current treatment alternatives. NeuroStar treatment offers our psychiatrist clients and their patients various advantages, such as clinically proven response and recovery with long-lasting outcomes, a demonstrated safety record with minimal treatment-related side effects, and high patient compliance. Furthermore, our therapy was developed to deliver a precise and repeatable office-based treatment that is also effective and convenient.